Gala Therapeutics Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Gala Therapeutics's estimated annual revenue is currently $2.8M per year.(i)
  • Gala Therapeutics's estimated revenue per employee is $251,000

Employee Data

  • Gala Therapeutics has 11 Employees.(i)
  • Gala Therapeutics grew their employee count by -52% last year.

Gala Therapeutics's People

NameTitleEmail/Phone
1
Sr. Manager, Clinical Data ManagementReveal Email/Phone
2
Clinical Study ManagerReveal Email/Phone
3
Clinical Research Associate IIReveal Email/Phone
4
Research EngineerReveal Email/Phone
5
Administrative AssistantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$20.3M817%N/AN/A
#2
$8.5M346%N/AN/A
#3
$4.5M18-10%N/AN/A
#4
$8M32-6%N/AN/A
#5
$5.3M210%N/AN/A
#6
$54.2M2169%N/AN/A
#7
$12M48N/AN/AN/A
#8
$10M405%N/AN/A
#9
$30.1M12022%N/AN/A
#10
$14.1M562%N/AN/A
Add Company

What Is Gala Therapeutics?

Gala Therapeutics is a privately-held medical device company based in Menlo Park, CA that was formed by Apple Tree Partners (www.appletreepartners.com), a $1.5B healthcare-focused venture capital firm based in NYC. Gala is dedicated to developing disease modifying therapies that improve survival, quality of life, and outcomes for patients with lung cancer, COPD, asthma, and other pulmonary diseases. Gala is building a portfolio of technologies to address the needs of interventional pulmonologists, thoracic surgeons, and all physicians who treat pulmonary disease.

keywords:N/A

N/A

Total Funding

11

Number of Employees

$2.8M

Revenue (est)

-52%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1M11-21%N/A
#2
$1.7M1122%N/A
#3
$1M1110%N/A
#4
$1.4M11-15%$51.5M
#5
$0.4M11-8%$10M